Elisabeth Ralfkiær - Concepedia

Author

Elisabeth Ralfkiær

Also Known As

E RALFKIAER, E Ralfkiaer, E. RALFKIAER, E. RALFKIÆR, E. RalfkiAEr, E. Ralfkiaer, E. Ralfkiær, ELISABETH RALFKIAER, ELISABETH Ralfkiaer, Elisabeth M Ralfkiaer

251

Publications

16.6K

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet University of Copenhagen Uppsala University Hospital Lund University Helsinki University Hospital

About

Elisabeth Ralfkiær is an author at Rigshospitalet specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	2.1K
2	Cell Biology	5	5	978
3	Health Sciences	4	4	588
4	Allergy	2	2	202
5	Public Health	1	1	257

Elisabeth Ralfkiær

Publications

Citations

H-Index

Page 1

	Year	Citations
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group Christian H. Geisler, Arne Kolstad, Anna Laurell, Blood	2008	619
A Dual Program for Translation Regulation in Cellular Proliferation and Differentiation Hila Gingold, Disa Tehler, Nanna R. Christoffersen, Cell Developmental BiologyCell RegulationCell DivisionCell ControlTranslation Regulation	2014	493
Nordic <scp>MCL</scp>2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by <scp>BEAM</scp> or <scp>BEAC</scp> + autologous stem‐cell support: still very long survival but late relapses do occur Christian H. Geisler, Arne Kolstad, Anna Laurell, British Journal of Haematology Cell TherapyImmunologyPathologyCell Replacement TherapyImmunotherapy	2012	265
Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia Mikkel Rosendahl, Morten Andersen, Elisabeth Ralfkiær, Fertility and Sterility MedicineReproductive HealthFemale PatientsGynecologyPathology	2010	257
Urokinase- and Tissue-Type Plasminogen Activators in Keratinocytes During Wound Reepithelialization In Vivo J Grøndahl-Hansen, Leif R. Lund, Elisabeth Ralfkiær, Journal of Investigative Dermatology Tissue EngineeringRegenerative MedicineTissue-type Plasminogen ActivatorsCutaneous BiologyWound Care	1988	239
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (<scp>MCL</scp>2): prolonged remissions without survival plateau Christian Winther Eskelund, Arne Kolstad, Mats Jerkeman, British Journal of Haematology ImmunologyPathologyHematological MalignancyOncologyHematology	2016	207
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT) Christian H. Geisler, Arne Kolstad, Anna Laurell, Blood	2009	184
Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells T. Grève, Erik Clasen‐Linde, Morten Andersen, Blood	2012	161
The Histone Methyltransferase and Putative Oncoprotein MMSET Is Overexpressed in a Large Variety of Human Tumors Heidi Rye Hudlebusch, Eric Santoni‐Rugiu, Ronald Simon, Clinical Cancer Research	2011	139
Histone deacetylase 1, 2, 6 and acetylated histone H4 in B‐ and T‐cell lymphomas Lena Marquard, Christian Bjørn Poulsen, Lise Mette Rahbek Gjerdrum, Histopathology	2009	130

Page 1